Enlivex Therapeutics
ENLV
ENLV
14 hedge funds and large institutions have $2.05M invested in Enlivex Therapeutics in 2016 Q2 according to their latest regulatory filings, with 6 funds opening new positions, 1 increasing their positions, 4 reducing their positions, and 2 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
14
Holders Change
+4
Holders Change %
+40%
% of All Funds
0.37%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
6
Increased
1
Reduced
4
Closed
2
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
Top Sellers
| 1 |
VAM
Visium Asset Management
New York
|
-$1.06M |
| 2 |
SM
Sabby Management
Miami Beach,
Florida
|
-$486K |
| 3 |
VKH
Virtu KCG Holdings
New York
|
-$54K |
| 4 |
OC
Oppenheimer & Co
New York
|
-$17.3K |
| 5 |
UBS Group
Zurich,
Switzerland
|
-$4K |
| Name | Holding | Trade Value |
Shares Change |
Shares Change % |
|
|---|---|---|---|---|---|
|
SM
1
Sabby Management
Miami Beach,
Florida
| $1.33M | -$486K | -7,592 | -27% |
|
|
KCM
2
Knoll Capital Management
Miami,
Florida
| $402K | – | – | – |
|
|
OC
3
Oppenheimer & Co
New York
| $82K | -$17.3K | -272 | -17% |
|
|
VAM
4
Visium Asset Management
New York
| $81K | -$1.06M | -16,570 | -93% |
|
5
HighTower Advisors
Chicago,
Illinois
| $57K | – | – | – |
|
6
Renaissance Technologies
New York
| $39K | +$39K | +603 | New |
|
|
BFA
7
BlackRock Fund Advisors
San Francisco,
California
| $27K | +$27K | +420 | New |
|
|
WS
8
Wedbush Securities
Los Angeles,
California
| $27K | +$27K | +425 | New |
|
|
LTFS
9
Ladenburg Thalmann Financial Services
Miami,
Florida
| $2K | – | – | – |
|
|
AIM
10
Acrospire Investment Management
Chicago,
Illinois
| $2K | +$2K | +25 | New |
|
|
BIM
11
BlackRock Investment Management
Wilmington,
Delaware
| $2K | +$2K | +31 | New |
|
12
Morgan Stanley
New York
| $1K | +$923 | +12 | +1,200% |
|
|
VKH
13
Virtu KCG Holdings
New York
| – | -$54K | -544 | Closed |
|
|
14
UBS Group
Zurich,
Switzerland
| – | -$4K | -42 | Closed |
|